Hair regeneration
For androgenetic hair loss and physician-defined scalp protocols.
IMPACT is a versatile platform for autologous preparations — from precisely separated cellular fractions to the body’s own regenerative signalling environment, with a particular focus on the secretome. Really simple to use. Unmatched in precision.
For healthcare professionals. Treatment selection remains a medical decision.
Many systems focus on a single concentration value. IMPACT opens access to different autologous preparations — and therefore to different biological signalling profiles. Our ACS serum is the IMPACT-secretome: a network of anti-inflammatory cytokines, growth factors and extracellular-vesicle-associated signals.
Potential applications for physician-led regenerative bioaesthetics. The appropriate preparation and protocol depend on the individual diagnosis and treatment concept.
For androgenetic hair loss and physician-defined scalp protocols.
For regenerative treatment concepts addressing texture, elasticity and fine lines.
For individualized approaches to fine lines and selected indications around the eyes.
As a stand-alone or complementary regenerative treatment concept.
For physician-led protocols, including combinations with microneedling or energy-based treatments.
To support regenerative care after selected laser, microneedling or aesthetic procedures.
Different aesthetic indications require different biological profiles. IMPACT enables physicians to prepare distinct autologous fractions through standardized, automated separation.
Blood is not a single active ingredient. Depending on the preparation, cellular components and soluble mediators are weighted differently — creating distinct biological signalling profiles.
Platelets, blood cells, plasma proteins and soluble mediators all originate from the patient.
The preparation process determines which cellular and soluble components are enriched — or released into serum.
Growth factors, cytokines and extracellular-vesicle-associated signals form a multi-factor communication network.
These signals can influence processes involved in inflammation, angiogenesis, fibroblast activity, matrix turnover and tissue repair.
During conditioning, blood cells release soluble mediators into the serum. After separation, the IMPACT-secretome contains a complex spectrum that includes anti-inflammatory cytokines such as IL-1Ra and IL-10, together with growth factors and other signalling components.
PRP concentrates platelets. Following activation, platelet α-granules release mediators including PDGF, TGF-β and VEGF. These factors participate in cell migration and proliferation, angiogenesis and extracellular-matrix remodelling.
APC places the emphasis on a concentrated cellular preparation. Its biological profile is shaped by cellular composition and activation state — parameters that influence the pattern of locally released signalling molecules.
The relevant biological variable is the profile: cellular versus cell-free, concentration, activation and the balance of signalling mediators. IMPACT is designed to prepare differentiated autologous profiles through standardized separation rather than treating every blood derivative as the same product.
The IMPACT platform is not comparable to conventional centrifuges. It is the technological heart of the platform: automated, standardized separation in a clinically intuitive workflow. Together with the dedicated IMPACT-secretome (ACS), PRP and APC packagings, the system communicates precision, modularity and a coherent product family. Made in Germany.
Talk to us about the platform, centrifuge and application-specific consumables.
The IMPACT platform combines an intuitive workflow with automated separation in a closed system.
Autologous venous blood is collected according to the selected preparation protocol.
The IMPACT platform performs standardized centrifugation and separation.
PRP, APC or the IMPACT-secretome is prepared through a structured, reproducible workflow.
The selected autologous preparation is applied according to indication and treatment concept.
One platform, differentiated autologous profiles — from platelet-focused preparations to the IMPACT-secretome. Designed for physician-led concepts that work with the patient’s own biology.
IMPACT and PLASMACONCEPT combine certified quality management with European medical-device compliance and regulated pharmaceutical distribution standards.
All IMPACT products meet the requirements of the European Medical Device Regulation 2017/745.
Certified quality-management processes for the manufacture and regulatory control of medical devices.
Certified quality management system for medical devices and regulatory requirements.
Discover how secretome-focused positioning can give you and IMPACT a more distinctive presence in aesthetic medicine.
Interested in partnering with us?
We look forward to hearing from you.